News

A study published in The Annals of Family Medicine examined if gaining housing increased rates of colorectal and breast ...
Scientists have made a major breakthrough in treating breast cancer by removing the building blocks that allow the killer ...
A month after Cassandra finished chemotherapy, in June 2023, her younger sister Katelyn was diagnosed with the same type of ...
At a stroke, the data gives Celcuity a potential advantage over already-marketed oral PI3K inhibitors like Novartis' ...
A phase 3 trial of Celcuity’s breast cancer combination has hit its primary endpoints, blasting past the biotech’s bar for ...
A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...
Breast cancer rates among women are on the rise, and doctors are pointing to alcohol as a potential contributing factor.
Celcuity said on Monday its experimental combination treatment delayed the progression of a type of advanced breast cancer in a late-stage study, sending the biotech firm's shares surging to a record ...
Celcuity’s stock jumps after Phase 3 trial shows gedatolisib slashes progression risk in breast cancer patients by up to 76%.
There’s overwhelming community support for a beloved Montgomery County restaurant owner fighting Stage 4 breast cancer.
Breast cancer rates are on the rise, and doctors fear that alcohol could be a big reason why. CNN’s Meg Tirrell speaks to an ...
Bone health management varies across hospitals for older women with early breast cancer who have inconsistent bone density ...